Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
about
Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
description
clinical trial
@en
klinisch onderzoek
@nl
name
Azacitidine With or Without Le ...... hronic Myelomonocytic Leukemia
@en
type
label
Azacitidine With or Without Le ...... hronic Myelomonocytic Leukemia
@en
prefLabel
Azacitidine With or Without Le ...... hronic Myelomonocytic Leukemia
@en
P4844
P6153
P1476
A Randomized Phase II/III Stud ...... Myelomonocytic Leukemia (CMML)
@en
P3098
NCT01522976
P580
2012-03-01T00:00:00Z
P582
2015-06-01T00:00:00Z